指南与共识骨质疏松与代谢性骨病

西班牙骨质疏松症达标治疗共识

Spanish consensus on treat to target for osteoporosis.
指南 / 共识 · Osteoporos Int · 2017-11-24

该研究通过德尔菲共识法,组织112名专家(第一轮)和106名专家(第二轮)参与,其中59.8%为风湿科医生,平均临床经验21.3年(标准差8.5),旨在达成西班牙骨质疏松症达标治疗(T2T)策略的专家共识。共识在70%的条目上达成,明确了治疗目标、患者随访方案、治疗失败标准及T2T策略中的治疗选择。

要点

  • 共识定义了骨质疏松症T2T策略的治疗目标,包括骨密度值(腰椎T值>-2.5 SD,股骨颈>-2.5/-2.0 SD)、无骨折及FRAX骨折风险。
  • 专家共识认为治疗失败为未实现显著骨密度增长或2-3年内发生新骨折。
  • 所有提出的治疗方案均应通过T2T策略达到治疗目标,共识评分最高的药物为地舒单抗和特立帕肽。

核心结论

  • 由专家小组确立了西班牙骨质疏松症T2T策略的治疗目标、患者随访方案、治疗失败标准及适当的治疗选择。
  • 某些方面仍需进一步分析。

研究设计与样本

  • 德尔菲共识研究,由科学委员会主导专家小组识别和问卷开发,完成两轮德尔菲调查。
  • 第一轮问卷包含24个条目,采用七点李克特量表评估专家对每个主题(适用性、治疗目标、患者随访、可能处方的治疗)的意愿(W)和5年预后(P)。
  • 第一轮未达成共识的条目纳入第二轮。
  • 共识定义为≥75%同意(有些同意/大部分同意/完全同意)或不同意(有些不同意/大部分不同意/完全不同意)的回答。
  • 第一轮和第二轮分别有112名和106名专家完成。

主要发现

  • 59.8%的专家为风湿科医生,平均临床经验21.3年(标准差8.5)。
  • 70%的条目达成共识,涉及T2T策略用于定义治疗目标、最佳随访和治疗算法的效用。
  • 参与者同意骨密度值(腰椎T值>-2.5 SD,股骨颈>-2.5/-2.0 SD)、无骨折和骨折风险(FRAX)作为治疗目标。
  • 对于测量骨密度变化,共识认为髋部和股骨颈部位合适。
  • 专家同意将无法实现显著骨密度增长或2-3年内发生新骨折视为治疗失败。

关键数值与推荐

  • 共识定义为≥75%同意(有些同意/大部分同意/完全同意)或不同意(有些不同意/大部分不同意/完全不同意)的回答。
  • 治疗目标包括骨密度值(腰椎T值>-2.5 SD,股骨颈>-2.5/-2.0 SD)、无骨折和骨折风险(FRAX)。
  • 治疗失败定义为无法实现显著骨密度增长或2-3年内发生新骨折。
  • 所有提出的治疗方案均应通过T2T策略达到治疗目标,共识评分最高的治疗为地舒单抗和特立帕肽。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: To reach a Spanish expert consensus on a treat-to-target strategy in osteoporosis, a Delphi Consensus Study has been developed. Most of the experts (59.8%) were rheumatologist with a mean clinical experience of 21.3 years (SD 8.5). Consensus was achieved for 70% of the items. Therapeutic objectives, patient follow-up scheme, treatment failure criteria, and appropriate treatment choice for use in T2T strategy in Spain have been defined. INTRODUCTION: The paper aims to achieve a Spanish expert consensus on a treat-to-target (T2T) strategy in osteoporosis. METHODS: A scientific committee led the project and was involved in expert panel identification and Delphi questionnaire development. Two Delphi rounds were completed. The first-round questionnaire included 24 items and assessed, using a seven-point Likert scale, the experts' wish (W) and prognosis (P) in 5 years for each topic (applicability, therapeutic objectives, patient follow-up, and possible treatment to be prescribed). Items for which there was no consensus in the first round were included in the second round. Consensus was defined as ≥75% agreement (somewhat/mostly/entirely agree) or disagreement (somewhat/mostly/entirely disagree) responses. RESULTS: Of the experts, 112 and 106 completed the first and second rounds, respectively. 59.8% were rheumatologists with a mean clinical experience of 21.3 years (SD 8.5). Consensus was achieved for 70% of the items, and was established regarding the utility of a T2T strategy to define therapeutic objectives, optimal follow-up, and therapeutic algorithm. Participants agreed on the utility of the bone mineral density (BMD) value (T-score >-2.5 SD for spine and >-2.5/-2.0 SD for femoral neck), lack of fractures, and fracture risk (FRAX) as therapeutic objectives. For measuring BMD changes, consensus was achieved on the suitability of hip and femoral neck locations. Experts agreed to consider treatment failure as when a significant BMD gain could not be achieved, or when a new fracture occurs within 2-3 years. There was consensus that all proposed therapies should achieve a therapeutic target through T2T strategy (treatments with the highest consensus scores were denosumab and teriparatide). CONCLUSION: The therapeutic objectives, patient follow-up scheme, treatment failure criteria, and appropriate treatment choice for use in T2T strategy in Spain have been established by a panel of experts. Some aspects nevertheless still require further analysis.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Nogués X, Nolla JM, Casado E, et al. Spanish consensus on treat to target for osteoporosis. Osteoporos Int. 2017. PMID: 29177559. doi:10.1007/s00198-017-4310-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。